Project Grant 1415757

Grant Award Summary Molecular Intelligence LLC received a $435,882 Small Business Innovation Research (SBIR) Phase I project grant from the National Institute of General Medical Sciences under the Biomedical Research and Research Training program (CFDA 93.859), effective September 1, 2025, with completion targeted for February 28, 2027. The award funds development of advanced artificial intelligence-powered software tools designed to model receptor-ligand interactions from cryo-electron...

This $275,000 Small Business Innovation Research (SBIR) Phase I award from the National Science Foundation (NSF) Technology, Innovation, and Partnerships (TIP) program (CFDA 47.084) supports Prhobe Inc.'s development of an innovative logistics tracking system. The project aims to revolutionize logistics and transport management by providing real-time visibility at the serial number level through the integration of wireless technologies including RFID, UWB, and cellular. The system will attach to...

Federal Cooperative Agreement Summary Award Details: Iiam Corporation received a $1.25 million Cooperative Agreement from the National Science Foundation (NSF) Technology, Innovation, and Partnerships (TIP) program (CFDA 47.084), effective July 15, 2025, with completion targeted for June 30, 2027. The project will be performed in San Francisco, California. Products and Services: This Small Business Innovation Research (SBIR) Phase II project delivers a Natural Language Processing (NLP)-driven...

Hidalga Technologies, Inc. received a $304,935 Small Business Innovation Research (SBIR) Phase I Project Grant from the National Science Foundation (NSF) under the Technology, Innovation, and Partnerships (TIP) program (CFDA 47.084) for the period of October 1, 2025 through September 30, 2026. The company will develop and validate an artificial intelligence (AI)-driven platform designed to automate prior authorization (PA) processing workflows in oncology specialty healthcare. The platform...

Mindtrace Technologies, Inc. received a $1.2M Cooperative Agreement award from the National Science Foundation (NSF) under the Technology, Innovation, and Partnerships (TIP) program (CFDA 47.084), effective May 15, 2025, through April 30, 2027. The company is developing a novel cognitive dashboard software platform designed to support clinical decision-making in neurosurgery by integrating multiple data sources including behavioral assessments, functional brain mapping protocols, and...

This $275,000 Small Business Innovation Research (SBIR) Phase I award from the National Science Foundation (NSF) Technology, Innovation, and Partnerships (TIP) program supports the development of a label-free, high-resolution, high-throughput protein screening platform called Vibrational Spectroscopy with Metasurface Optics (VISMO). The technology aims to enable simultaneous, minute-scale measurement of millions of protein samples, which would dramatically improve the lengthy and costly cycles...

This $274,990 Small Business Innovation Research (SBIR) Phase I award from the National Science Foundation (CFDA 47.084 - NSF Technology, Innovation, and Partnerships) supports the development of a physics-based machine learning platform for predicting the crystal structure of small drug molecules. The technology aims to accelerate and reduce the cost of early-stage pharmaceutical research and development by computationally analyzing the crystal structure properties that determine key...

This $274,786 Phase I Small Business Innovation Research (SBIR) award from the National Science Foundation's (NSF) Technology, Innovation, and Partnerships (TIP) program (CFDA 47.084) will fund the development of a cutting-edge scanning magnetometer microscope by Femtosenselabs, LLC. This new microscope technology will enable high-resolution imaging of novel magnetic materials with unprecedented sensitivity at the nanoscale, supporting the advancement of spintronics and the development of...

The U.S. National Science Foundation (NSF) awarded a $303,864 Phase I Small Business Innovation Research (SBIR) grant under the NSF Technology, Innovation, and Partnerships (CFDA 47.084) program to Core Biotherapeutics, Inc. (UEI N9FGZ15RQGJ4) located in Ladera Ranch, CA. The project aims to develop a platform for discovering therapeutic drug candidates that can modulate molecular networks driving diseases, with the potential to produce disease-modifying effects for neurodegenerative...

The National Science Foundation (NSF) awarded Insilicom LLC a $275,000 SBIR Phase I Project Grant under the NSF Technology, Innovation, and Partnerships (CFDA 47.084) program. The grant supports the development of AI-powered, commercially viable applications enabled by Insilicom's large-scale biomedical knowledge graph. Key objectives include increasing the coverage of the knowledge graph, building a novel literature alert system called iPulse, and enhancing Insilicom's versatile query interface...